Swan Capital’s Tiziana Life Sciences TLSA Stock Holding History

Swan Capital’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-500	Closed	-$348	–	417
2024 Q4	$348	Buy	+500	New	+$463	﹤0.01%	338

Other funds holding TLSA

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Swan Capital's TLSA Position: Q1 2025 in Review

Swan Capital sold out of Tiziana Life Sciences (TLSA) in Q1 2025, closing a stake of 500 shares — an estimated $348 sold.

Swan Capital first reported a position in TLSA in Q4 2024 and held it in 1 quarter. The position peaked at $348 in Q4 2024. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2025.

Swan Capital reported no remaining Tiziana Life Sciences position as of Q1 2025 after selling out during the quarter.
Swan Capital sold 500 Tiziana Life Sciences shares in Q1 2025, an estimated $348.
Swan Capital first reported a position in Tiziana Life Sciences in Q4 2024 and held it in 1 quarter.
Swan Capital's Tiziana Life Sciences position peaked at $348 in Q4 2024.
32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2025.

Based on Swan Capital's 13F filing for Q1 2025, filed 23 May 2025.